Most laboratories flag TPO antibody levels above 34–35 IU/mL as positive, but the threshold that best predicts Hashimoto’s-related hypothyroidism is probably lower, somewhere around 15–18 IU/mL depending on the assay and the population studied. The honest answer is that no single number cleanly separates “has Hashimoto’s” from “does not,” because the diagnosis rests on more than antibody levels alone. Your TPO result is one piece of a picture that includes thyroid hormone levels, ultrasound findings, and sometimes biopsy.
Why There Is No Universal Cutoff
TPO antibody testing has become extraordinarily sensitive. Modern assays can detect very low titers in virtually all subjects, meaning that trace amounts of these antibodies circulate in healthy people with no thyroid disease at all.1PubMed. Thyroid peroxidase autoantibodies in euthyroid subjects The challenge is drawing a meaningful line between “normal background noise” and “immune attack on the thyroid.” That line shifts depending on the assay manufacturer, the reference population used to calibrate it, and whether the goal is screening for current hypothyroidism or predicting future risk.
Each lab kit has its own cutoff, which is why your report might say “positive above 35 IU/mL” while a friend’s report from a different lab says “positive above 9 IU/mL.” These numbers come from the manufacturer’s validation studies, not from a universal standard handed down by an international body. When your doctor interprets the result, the number matters less than where it falls relative to that particular assay’s reference range.
What the Research Says About Diagnostic Cutoffs
A large population study in Tehran calculated reference intervals for TPO antibodies using thousands of participants free of thyroid disease. The upper limit of normal (the 97.5th percentile) was about 33 IU/mL for men and 35 IU/mL for women. But when researchers asked what cutoff best predicted clinical or subclinical hypothyroidism, the optimal thresholds were lower: roughly 18 IU/mL for predicting overt hypothyroidism and about 15 IU/mL for subclinical hypothyroidism.2PubMed. Sex- and Age-Specific Reference Values and Cutoff Points for TPOAb: Tehran Thyroid Study A separate study using receiver operating curves to find the best predictor of hypothyroidism landed on a very similar number: TPO titers above 17 IU/mL flagged hypothyroidism with about 90% sensitivity.3Annals of Agricultural and Environmental Medicine. Anti-thyroidal peroxidase antibodies are associated with thyrotropin levels in hypothyroid patients and in euthyroid individuals
These findings suggest that the cutoffs printed on many standard lab reports may be set too high for early detection. A result of, say, 25 IU/mL might come back labeled “within normal limits” on a report that uses a 35 IU/mL threshold, yet that level could carry real predictive weight for future thyroid trouble. This is one reason endocrinologists often look at the actual number rather than just whether it is flagged positive or negative.
How Accurate Is the Test?
TPO antibody testing is good at confirming autoimmune thyroiditis when the clinical picture already points that way, but it is not a perfect standalone tool. One study using surgical pathology as the gold standard found that TPO antibody detection was extremely specific for autoimmune thyroid inflammation, around 97%, and that higher titers correlated with more severe inflammation in the tissue.4PubMed. Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results That high specificity means a clearly positive result is unlikely to be a false alarm. But sensitivity varies by study. One investigation reported roughly 88% sensitivity using cytology as the reference.5Journal of Evidence Based Medicine and Healthcare. Diagnostic Accuracy of Anti-Thyroid Antibodies in Hashimoto’s Thyroiditis Another found even higher sensitivity at nearly 90%, paired with complete specificity, when combining TPO antibody gene expression analysis with standard lab markers.6The Journal of Basic and Applied Zoology. Anti-TPO and anti-TSHR antibodies in combination with T3, T4, and TSH exhibited a diagnostic curve for Hashimoto patients
In practical terms, this means a positive TPO result in someone with an elevated TSH is strongly suggestive of Hashimoto’s. A negative result, however, does not rule it out.
When TPO Antibodies Are Negative but You Still Have Hashimoto’s
Roughly 10–15% of people with confirmed Hashimoto’s thyroiditis have no detectable TPO antibodies in their blood, a condition sometimes called seronegative Hashimoto’s. A pediatric study found that about 12% of children diagnosed with Hashimoto’s fell into this category, and they tended to have milder hypothyroidism at the time of diagnosis compared to children who tested antibody-positive.7PubMed. Seronegative phenotype in a pediatric population with Hashimoto’s thyroiditis
For seronegative cases, thyroid ultrasound fills the diagnostic gap. The hallmark finding is a diffusely hypoechoic (darker than normal) thyroid gland, sometimes described as having a heterogeneous or mottled texture. When a patient has hypothyroidism plus this ultrasound pattern and negative antibodies, that combination is considered the main basis for diagnosing seronegative autoimmune thyroiditis.8PubMed Central. AI-Assisted Ultrasound for the Early Diagnosis of Antibody-Negative Autoimmune Thyroiditis This matters if your antibodies came back normal but your doctor still suspects Hashimoto’s based on your symptoms and TSH: the ultrasound can clinch the diagnosis without a biopsy.
Positive TPO Antibodies Without Hypothyroidism
Having elevated TPO antibodies does not automatically mean you have Hashimoto’s right now. In a large population-based study, about 13% of participants were TPO-positive at baseline, with women affected about twice as often as men.9PubMed Central. The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study Many of these people had perfectly normal thyroid function at the time of testing. The antibodies serve more as a risk marker than a diagnosis in this context. Data from the Whickham survey, a landmark population study, showed that TPO-positive women with normal TSH had a yearly risk of developing hypothyroidism of about 2%, which accumulated substantially over a decade.1PubMed. Thyroid peroxidase autoantibodies in euthyroid subjects
The Rotterdam Study, which followed nearly 10,000 middle-aged and older adults, found that female sex was a strong predictor of TPO antibody positivity, while higher age was associated with somewhat lower odds of detectable antibodies. Current smoking, interestingly, was associated with roughly triple the odds of having detectable TPO antibodies, while alcohol consumption appeared to lower those odds modestly.10PubMed. Determinants and Clinical Implications of Thyroid Peroxidase Antibodies in Middle-Aged and Elderly Individuals: The Rotterdam Study These population patterns help explain why a positive TPO result can show up on routine blood work without any immediate thyroid symptoms.
TPO Antibodies in Graves’ Disease and Other Autoimmune Conditions
TPO antibodies are not exclusive to Hashimoto’s. About 60% of people with Graves’ disease also test positive for them, which can create diagnostic confusion when someone presents with thyroid dysfunction and a positive TPO result.11PubMed Central. The Clinical Implications of Anti-thyroid Peroxidase Antibodies in Graves’ Disease in Basrah The distinction between the two conditions depends on the clinical picture: Hashimoto’s typically causes hypothyroidism, while Graves’ causes hyperthyroidism. Testing for TSH receptor antibodies helps sort this out when TPO antibodies are positive but the direction of thyroid dysfunction is unclear.
In Graves’ disease specifically, being TPO-positive seems to predict a rougher course. One study found that TPO-positive Graves’ patients required longer treatment, had higher relapse rates after stopping medication, and were more likely to need radioactive iodine therapy.12Endocrine Abstracts. The presence of thyroid peroxidase antibodies in Graves’ disease is predictive of disease duration and relapse rates Another found that TPO-positive Graves’ patients who received radioactive iodine treatment were more likely to develop hypothyroidism afterward, with about 88–89% becoming hypothyroid compared to roughly 72% of those who were TPO-negative.13European Thyroid Journal. TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease
TPO antibodies also show up more often in people with other autoimmune diseases, particularly type 1 diabetes and celiac disease. Researchers studying children with these conditions have found elevated TPO antibody rates, reflecting the tendency of autoimmune diseases to cluster together.14PubMed Central. Inflammatory Immune Markers Associated With Thyroid Peroxidase Autoantibodies in Children Diagnosed With Both Type 1 Diabetes and Celiac Disease If you have one autoimmune condition, your doctor may screen your TPO antibodies even if your thyroid feels fine, because the overlap is common enough to warrant surveillance.
TPO Antibodies and Pregnancy
Pregnancy is where TPO antibody levels carry outsized importance, even in women whose thyroid function tests look normal. Elevated TPO antibodies in euthyroid pregnant women are associated with roughly 2.5 times the risk of miscarriage compared to antibody-negative women.15PubMed Central. Impact of Thyroid Autoantibodies on Pregnancy Outcomes in Euthyroid Women: A Prospective Cohort Study One study from a tertiary care center found that miscarriage rates were 12% in TPO-positive pregnant women versus about 3% in TPO-negative women, and preterm deliveries followed a similar pattern at 14% versus 3%.16PubMed Central. Prevalence of Thyroid Peroxidase Antibody and Pregnancy Outcome in Euthyroid Autoimmune Positive Pregnant Women from a Tertiary Care Center in Haryana
The postpartum period is also a vulnerable window. Women with positive TPO antibodies during the first trimester are at higher risk for postpartum thyroid dysfunction, and higher antibody trajectories throughout pregnancy predict hypothyroidism at 12 months postpartum.17PubMed. Effect of thyroid peroxidase antibody titers trajectories during pregnancy and postpartum on postpartum thyroid dysfunction This is one reason many obstetric guidelines recommend TPO testing early in pregnancy for women with a history of thyroid problems, a family history of autoimmune disease, or elevated TSH.
What Triggers Elevated TPO Antibodies
The immune system’s decision to attack thyroid peroxidase, the enzyme your thyroid uses to produce hormones, results from a collision between genetic susceptibility and environmental triggers. The best-established environmental factor is excess dietary iodine, which can provoke thyroiditis in genetically predisposed people. But iodine is not the only culprit: infections and certain environmental chemicals have also been implicated as triggers that can initiate or worsen autoimmune thyroiditis.18PubMed Central. Environmental triggers of autoimmune thyroiditis The difference in antibody actions between Hashimoto’s and Graves’ relates to where the target antigens sit on the thyroid cell, how high the antibody titers are, and how long the immune exposure lasts.19PubMed Central. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
Do TPO Antibody Levels Change with Treatment?
They do, though slowly. In a long-term follow-up of Hashimoto’s patients taking levothyroxine (the standard thyroid hormone replacement), about 92% showed a decline in TPO antibodies over time. The drop was gradual: about 8% after three months, 45% after one year, and 70% after five years. Even so, only about 16% of patients saw their antibodies fall to fully negative levels (below 100 IU/mL).20PubMed. Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) treated with levothyroxine This means that most people on levothyroxine will still test positive for TPO antibodies, just at progressively lower levels. The treatment targets thyroid hormone levels, not the antibodies themselves.
Selenium supplementation has generated interest as a way to lower TPO antibody titers. A randomized controlled trial found that selenium-treated patients had significantly lower TPO antibodies after six months compared to a control group.21PubMed Central. Effect of selenium on thyroid autoimmunity and regulatory T cells in patients with Hashimoto’s thyroiditis: A prospective randomized‐controlled trial An overview of systematic reviews confirmed that this TPO-lowering effect holds at three and six months, both in patients already taking levothyroxine and in those who are not, although the effect seems to fade by 12 months in the non-levothyroxine group. The overall certainty of the evidence was rated very low.22PubMed Central. The Effects of Selenium Supplementation in the Treatment of Autoimmune Thyroiditis: An Overview of Systematic Reviews Importantly, lowering antibody titers has not been shown to reliably change how the thyroid actually functions, which is ultimately what determines whether you feel well. Selenium may nudge a lab number in the right direction without meaningfully altering the disease course, and excess selenium carries its own toxicity risks.
The Autoimmune Protocol Diet and TPO Levels
The autoimmune protocol (AIP) diet, which eliminates grains, dairy, eggs, legumes, nightshades, and other foods thought to promote inflammation, has a dedicated following among Hashimoto’s patients. The evidence so far is thin and mixed. A supported lifestyle intervention that included the AIP diet found no statistically significant changes in thyroid function or antibody levels after the study period.23PubMed Central. Efficacy of the Autoimmune Protocol Diet as Part of a Multi-disciplinary, Supported Lifestyle Intervention for Hashimoto’s Thyroiditis Another study observed that while participants on an AIP diet felt better subjectively and some thyroid hormone levels shifted slightly, TPO antibodies actually increased significantly.24Annals of Agricultural and Environmental Medicine. Effects of Autoimmune Protocol (AIP) diet on changes in thyroid parameters in Hashimoto’s disease
These results should temper expectations. Feeling better on a restrictive diet could reflect genuinely reduced inflammation, improved gut health, or simply a placebo response from taking active control of one’s health. But the antibody data do not currently support the claim that the AIP diet reduces the autoimmune attack on the thyroid. That disconnect between subjective improvement and objective antibody trends is worth understanding if you are considering the diet specifically to lower your TPO numbers.
How Often Should You Recheck TPO Antibodies?
Once Hashimoto’s has been diagnosed, most endocrinologists do not routinely retest TPO antibodies at every visit. The antibodies confirmed the autoimmune nature of the disease, and that does not change. What your doctor monitors going forward is thyroid function: TSH and sometimes free T4 or free T3. Rechecking antibodies adds cost without changing treatment decisions in most cases, since levothyroxine dosing is adjusted based on hormone levels, not antibody titers.
There are exceptions. In pregnancy, tracking antibody trends can help predict postpartum thyroid dysfunction. In ambiguous diagnostic situations, such as distinguishing between Hashimoto’s and other causes of hypothyroidism, or evaluating someone whose ultrasound looks autoimmune but whose initial antibody test was borderline, a repeat test months later can be informative. And researchers sometimes monitor antibody levels in clinical trials to see whether an intervention is dampening the autoimmune process. But for the typical Hashimoto’s patient already on treatment, obsessing over your TPO number at every blood draw does not yield actionable information.
The Difference Between TPO Antibodies and Thyroglobulin Antibodies
Your lab panel may include both TPO antibodies and thyroglobulin (TgAb) antibodies, which target a different thyroid protein. TPO antibodies are more useful for diagnosing Hashimoto’s because they are more consistently elevated and have better diagnostic accuracy. Research has suggested that thyroglobulin antibody testing could be dropped from routine autoimmune thyroid disease workups and reserved for specific clinical situations, such as monitoring after thyroid cancer treatment where thyroglobulin is used as a tumor marker.25PubMed. Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases In practice, many doctors still order both, but if only one comes back positive, a positive TPO result carries more diagnostic weight for Hashimoto’s than a positive TgAb result alone.
A small percentage of Hashimoto’s patients will be positive for thyroglobulin antibodies but negative for TPO antibodies. This is one reason some labs include both on a thyroid antibody panel: the combination catches slightly more cases than either test alone. But TPO antibodies remain the workhorse test, and if you are only getting one antibody measured, it should be that one.